English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPenn Medicine researchers will help lead development of an algorithm to flag patients at risk of rare disease thanks to a $4.7 million NIH grant
Tag: Vasculitis
Vasculitis Foundation, International Organization for Vasculitis Community, Responding to the News of Ashton Kutcher’s Diagnosis of Vasculitis
The Vasculitis Foundation applauds Ashton Kutcher for publicly sharing his diagnosis of vasculitis.
Substudy of ADVOCATE Trial for ANCA-Associated Vasculitis Finds Avacopan Reduces Need for Glucocorticoids, Respiratory and ENT Involvement
Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement and enabled reduced glucocorticoid use in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial. Study results were published at the ATS 2022 international conference. The study was a subgroup analysis of results from the larger trial, which led to FDA approval of avacopan.
Pregnant Women with Takayasu’s Arteritis and Their Babies at High Risk for Serious Complications
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that pregnant women with Takayasu’s arteritis appear to have a high prevalence of serious maternal and fetal adverse outcomes
The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis
The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis.
The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis
The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis.
Winners Announced in Vasculitis Foundation’s 2021 V-RED award program
Along with a first-place winner, there are two honorable mentions in the Vasculitis Foundation’s (VFs) 2021 Recognizing Excellence in Diagnostics (V-RED) award program.
Medication Keeps More Patients with ANCA-Associated Vasculitis in Remission Than Steroids
Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone
Vasculitis Foundation’s Young Investigator Award Goes to Monash University Research Fellow
Dragana Odobasic, PhD, a research fellow at Monash University in Melbourne, Australia, was awarded the Vasculitis Foundation’s (VF) “Dr. Chris Cox-Marinelli Young Investigator Award” in May for her study, Tolerogenic Dendritic Cells for Antigen-Specific Immunosuppression in MPO-ANCA Vasculitis. The award, a one-year grant totaling $49,822, was created in memory of Chris Cox-Marinelli, MD, who was a strong advocate for promoting the development of junior investigators toward a career in vasculitis.
Register Now for Live COVID-19 Q&A Webinar Saturday with Vasculitis Experts!
Join the Vasculitis Foundation (VF) this Saturday, May 23, for a live Q&A webinar where vasculitis experts will discuss what they know about COVID-19 and immune-suppressed patients. The program starts at 9 a.m. Central Time.
Vasculitis Foundation Kicks Off Vasculitis Awareness Month 2020 Observance in May
The Race is On! That’s the theme for Vasculitis Awareness Month 2020, which runs May 1 through May 31, 2020, and shines a spotlight on vasculitis—a rare, but often serious autoimmune blood vessel disorder.